Literature DB >> 12930202

Should the European Union lift the ban on snus? Evidence from the Swedish experience.

Karl Olov Fagerström1, Elsy-Britt Schildt.   

Abstract

The very low smoking prevalence in Sweden has received considerable attention. Sweden was the only country in Europe to reach the World Health Organizations' goal of less than 20% daily smoking prevalence among adults by year 2000. Only 17% of Swedish men smoke. Some have argued that this has been achieved because Swedes use another form of tobacco instead. Sweden has a high level of use of a moist snuff product called 'snus'. Nineteen per cent of adult men and 1% of women are daily users and the trend is increasing. Epidemiological studies have failed to find evidence that snus causes cancers, including oral cancer. Its adverse effects on the cardiovascular system are debated, but are certainly less than those of smoking. Recent studies among former smokers indicate that many men have quit smoking using snus. Forty-seven per cent of current snus users are former smokers and 28% of ex-smoking used snus at their last attempt to stop smoking. The association between high snus consumption and low smoking prevalence has been debated and challenged. It has been argued that snus may be a gateway to cigarette smoking. Recent data has found that among those starting tobacco use in the form of snus, 20% later go on to smoking while the same risk for those not starting with snus is 43%. On balance, there is reason to believe that having snus available to the Swedish population has been of benefit to public health. Repealing the ban on snus in the rest of the European Union might also have some positive effect, depending on the marketing.

Entities:  

Mesh:

Year:  2003        PMID: 12930202     DOI: 10.1046/j.1360-0443.2003.00442.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  31 in total

1.  Oral tobacco products: preference and effects among smokers.

Authors:  Dorothy K Hatsukami; Joni Jensen; Amanda Anderson; Berry Broadbent; Sharon Allen; Yan Zhang; Herb Severson
Journal:  Drug Alcohol Depend       Date:  2011-04-23       Impact factor: 4.492

2.  Public health measures to reduce smoking prevalence in the UK: how many lives could be saved?

Authors:  S Lewis; D Arnott; C Godfrey; J Britton
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

3.  Public health implications of smokeless tobacco use as a harm reduction strategy.

Authors:  David A Savitz; Roger E Meyer; Jason M Tanzer; Sidney S Mirvish; Freddi Lewin
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

4.  Sweden SimSmoke: the effect of tobacco control policies on smoking and snus prevalence and attributable deaths.

Authors:  Aimee M Near; Kenneth Blackman; Laura M Currie; David T Levy
Journal:  Eur J Public Health       Date:  2013-11-27       Impact factor: 3.367

Review 5.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

6.  A Randomized Clinical Trial of Snus Examining the Effect of Complete Versus Partial Cigarette Substitution on Smoking-Related Behaviors, and Biomarkers of Exposure.

Authors:  Ellen Meier; Bruce R Lindgren; Amanda Anderson; Sarah A Reisinger; Kaila J Norton; Joni Jensen; Lori Strayer; Laura Dick; Mei-Kuen Tang; Menglan Chen; Steven G Carmella; Stephen S Hecht; Sharon E Murphy; Jing Yang; Irina Stepanov; Richard J O'Connor; Peter G Shields; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2020-04-17       Impact factor: 4.244

7.  Naturalistic assessment of demand for cigarettes, snus, and nicotine gum.

Authors:  Jeffrey S Stein; A George Wilson; Mikhail N Koffarnus; Michael C Judd; Warren K Bickel
Journal:  Psychopharmacology (Berl)       Date:  2016-10-11       Impact factor: 4.530

Review 8.  Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.

Authors:  Catalin Marian; Richard J O'Connor; Mirjana V Djordjevic; Vaughan W Rees; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

9.  The STAGE cohort: a prospective study of tobacco use among Swedish twins.

Authors:  Helena Furberg; Paul Lichtenstein; Nancy L Pedersen; Laura Thornton; Cynthia M Bulik; Caryn Lerman; Patrick F Sullivan
Journal:  Nicotine Tob Res       Date:  2008-12       Impact factor: 4.244

Review 10.  Review of epidemiologic data on the debate over smokeless tobacco's role in harm reduction.

Authors:  David S Timberlake; Jason A Zell
Journal:  BMC Med       Date:  2009-10-19       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.